Clinical trial Recruiting at 1 site Observational Ages 1 Day to 4 Months

Comparing gut microbiota in preterm and full-term infants

Official title: Gut Microbial Succession of Preterm Infants and Full-term Infants at Early Life

Run by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · NCT03373721 · Data updated 2026-11-12

This study looks at the differences in gut bacteria between preterm and full-term babies from birth to three months to see how things like antibiotic use affect their gut health.

Quick facts

Study typeObservational
Ages1 Day to 4 Months
SexAll
Enrollment102 (estimated)
SponsorXinhua Hospital, Shanghai Jiao Tong University School of Medicine
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedJuly 20, 2014
Main results expectedNovember 1, 2026
Study endsDecember 20, 2028
Registry record updatedApril 17, 2024
Trial IDNCT03373721 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are preterm infants born before 37 weeks of gestation and full-term infants born after 37 weeks without gastrointestinal disorders.

Probably not a fit

Patients who may not benefit from this study include those with gastrointestinal tract disorders, metabolic diseases, or who have experienced necrotizing enterocolitis.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to longitudinally analyze the gut microbial establishment in a cohort of 51 preterm infants compared to 50 full-term infants from birth to 90 days of age. The researchers will sequence the V3-V4 region of 16S rRNA amplicons from stool samples to examine differences in microbial profiles. The study will also investigate key clinical factors, such as antibiotic usage, that may influence the development of the neonatal gut microbiome. A statistical model will be employed to compare the bacterial groups over time while adjusting for variables like gestational age.

Why it matters

Potential benefit: If successful, this study could enhance our understanding of gut microbiome development in infants, potentially leading to improved health outcomes for preterm infants.

How similar studies have gone: Other studies have shown success in examining gut microbiota in infants, but this specific longitudinal approach comparing preterm and full-term infants is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Preterm infants

1. gestational age \<37 weeks;
2. no gastrointestinal tract disorders, metabolic diseases, or viral hepatitis;
3. hospital stay \> 7 days;

Exclusion criteria:

1. NICU stay less than 7 days
2. Necrotizing enterocolitis infant

Control group:

1. Full-term healthy infants;
2. gestational age \>37 weeks;
3. vaginally born;
4. no gastrointestinal tract disorders, metabolic diseases, or viral hepatitis.

Where it's running

  • Department of NICU, XinHua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
    Shanghai, China
    Recruiting

Study contacts

  • Principal investigator: Jie Jia, PhD — Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
  • Study coordinator: Jie Jia, PhD
  • Email: jie.jia@shsmu.edu.cn
  • Phone: 0086-13122322289

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.